resveratrol/neoplasms

CROSS REFERENCE OF RELATED APPLICATION This is a U.S. National Stage under 35 U.S.C 371 of the International Application PCT/CN2014/074242, filed Mar. 28, 2014, which claims priority under 35 U.S.C. 119(a-d) to CN 201410080996.1, filed Mar. 6, 2014. BACKGROUND OF THE PRESENT INVENTION Field of

BACKGROUND The recent explosion of obesity, type II diabetes, heart disease, and some cancers in the United States can be largely attributed to two key well-known factors, a lack of a healthy diet and reduced physical activity. Type II diabetes, high blood pressure, and heart disease are components

BACKGROUND The recent explosion of obesity, type II diabetes, heart disease, and some cancers in the United States can be largely attributed to two key well-known factors, a lack of a healthy diet and reduced physical activity. Type II diabetes, high blood pressure, and heart disease are components

CROSS-REFERENCE TO RELATED APPLICATION This non-provisional application claims priority under 35 U.S.C. .sctn.119(a) on Patent Application No(s). 097132616 filed in Taiwan, R.O.C. on Aug. 27, 2008, the entire contents of which are hereby incorporated by reference. BACKGROUND OF THE INVENTION 1.

BACKGROUND OF THE INVENTION In Alzheimer's Disease (AD), the abnormal cleavage of beta amyloid protein precursor from the intracellular membrane often produces a protein A.beta. 1-42 which is incompletely removed by normal clearance processes. It has been reported that soluble beta amyloid oligomers

CROSS-REFERENCE TO RELATED APPLICATIONS This United States utility patent application is the .sctn.371 national phase of PCT international patent application no PCT/SG2010/000147, having an international filing date of Apr. 13, 2010, which claims benefit of priority to Singapore Patent Applications

COPYRIGHT NOTICE A portion of the disclosure of this patent document contains material, which is subject to copyright protection. The copyright owner has no objection to the facsimile reproduction by anyone of the patent document or the patent disclosure, as it appears in the Patent and Trademark

FIELD OF THE INVENTION The disclosed invention is generally in the field of small molecule activators of deacetylase enzymes and the treatment of disorders including cancer, cardiovascular disease, inflammation, obesity, diabetes, and neurodegenerative diseases related to the activation of

BACKGROUND Resveratrol (3,4',5-trihydroxystilbene) (FIG. 1) is a naturally occurring phytoalexin produced by a variety of plants in response to stress. Resveratrol has wide pharmacological applications and is being investigated for the treatment of numerous conditions and/or disorders, such as

BACKGROUND Resveratrol (3,4',5-trihydroxystilbene) (FIG. 1) is a naturally occurring phytoalexin produced by a variety of plants in response to stress. Resveratrol has wide pharmacological applications and is being investigated for the treatment of numerous conditions and/or disorders, such as

TECHNICAL FIELD The present invention relates to a novel resveratrol polymerization compound or a pharmaceutically acceptable salt thereof and a method for manufacturing the same and relates to foods, pharmaceutical agents, quasi drugs, or cosmetics containing the resveratrol polymerization compound

FIELD OF INVENTION The present invention relates to a polyphenol derivative of the stilbenoid family, namely trans-3,5,4'-trihydroxybibenzyl, also known as dihydro-resveratrol, as a remedial agent. In particular, the present invention presents the usage of dihydro-resveratrol or its

FIELD OF INVENTION The present invention relates to a polyphenol derivative of the stilbenoid family, namely trans-3,5,4'-trihydroxybibenzyl, also known as dihydro-resveratrol, as a remedial agent. In particular, the present invention presents the usage of dihydro-resveratrol as an anti-fibrotic

FIELD OF INVENTION The present invention relates to a polyphenol derivative of the stilbenoid family, namely trans-3,5,4'-trihydroxybibenzyl, also known as dihydro-resveratrol, as a remedial agent. In particular, the present invention presents the usage of dihydro-resveratrol as an anti-fibrotic

TECHNICAL FIELD This invention generally relates to dietary supplement. It relates specifically to such dietary supplement compositions comprising lycopene and resveratrol exhibiting certain therapeutic effects, including anti-oxidant, anti-arthritis, suppressing carcinoma growth and mitigating